Literature DB >> 18381419

Origins and prevalence of the American Founder Mutation of MSH2.

Mark Clendenning1, Mark E Baze, Shuying Sun, Kyle Walsh, Sandya Liyanarachchi, Dan Fix, Victoria Schunemann, Ilene Comeras, Molly Deacon, Jane F Lynch, Gordon Gong, Brittany C Thomas, Stephen N Thibodeau, Henry T Lynch, Heather Hampel, Albert de la Chapelle.   

Abstract

Large germline deletions within the mismatch repair gene MSH2 account for a significant proportion (up to 20%) of all deleterious mutations of this gene which are associated with Lynch syndrome. An exons 1 to 6 deletion of MSH2, originally reported in nine families, has been associated with a founding event within the United States, which genealogic studies had previously dated to 1727, and the number of present day carriers was estimated to be 18,981. Here, we report the development of a robust multiplex PCR which has assisted in the detection of 32 new families who carry the MSH2 American Founder Mutation (AFM). By offering testing to family members, 126 carriers of the AFM have been identified. Extensive genealogic studies have connected 27 of the 41 AFM families into seven extended pedigrees. These extended families have been traced back to around the 18th century without any evidence of further convergence between them. Characterization of the genomic sequence flanking the deletion and the identification of a common disease haplotype of between 0.6 and 2.3 Mb in all probands provides evidence for a common ancestor between these extended families. The DMLE+2.2 software predicts an age of approximately 500 years (95% confidence interval, 425-625) for this mutation. Taken together, these data are suggestive of an earlier founding event than was first thought, which likely occurred in a European or a Native American population. The consequences of this finding would be that the AFM is significantly more frequent in the United States than was previously predicted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381419     DOI: 10.1158/0008-5472.CAN-07-6599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin.

Authors:  Iolanda Borelli; Marco A Barberis; Francesca Spina; Guido C Casalis Cavalchini; Caterina Vivanet; Luisa Balestrino; Monica Micheletti; Anna Allavena; Paola Sala; Carlo Carcassi; Barbara Pasini
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

2.  Spatiotemporal Analysis of Oklahoma Tobacco Helpline Registrations Using Geoimputation and Joinpoint Analysis.

Authors:  Naci Dilekli; Amanda Janitz; Sydney Martinez; Sameer Gopalani; Tyler Dougherty; Aaron Williams; Hamed Zamani Sabzi; Janis Campbell
Journal:  J Public Health Manag Pract       Date:  2019 Sep/Oct

3.  Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky.

Authors:  Tong Gan; Heather F Sinner; Samuel C Walling; Quan Chen; Bin Huang; Tom C Tucker; Jitesh A Patel; B Mark Evers; Avinash S Bhakta
Journal:  J Am Coll Surg       Date:  2019-02-22       Impact factor: 6.113

Review 4.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

5.  An American founder mutation in MLH1.

Authors:  Jerneja Tomsic; Sandya Liyanarachchi; Heather Hampel; Monika Morak; Brittany C Thomas; Victoria M Raymond; Anu Chittenden; Hans K Schackert; Stephen B Gruber; Sapna Syngal; Alessandra Viel; Elke Holinski-Feder; Stephen N Thibodeau; Albert de la Chapelle
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

6.  Incidence of CNS tumors in Appalachian children.

Authors:  Bin Huang; Alice Luo; Eric B Durbin; Ellen Lycan; Thomas Tucker; Quan Chen; Craig Horbinski; John L Villano
Journal:  J Neurooncol       Date:  2017-03-11       Impact factor: 4.130

7.  Mutation deep within an intron of MSH2 causes Lynch syndrome.

Authors:  Mark Clendenning; Daniel D Buchanan; Michael D Walsh; Belinda Nagler; Christophe Rosty; Bryony Thompson; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Joanne P Young
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

8.  How old is this mutation? - a study of three Ashkenazi Jewish founder mutations.

Authors:  Celia M T Greenwood; Shuying Sun; Justin Veenstra; Nancy Hamel; Bethany Niell; Stephen Gruber; William D Foulkes
Journal:  BMC Genet       Date:  2010-05-14       Impact factor: 2.797

9.  Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.

Authors:  Wenche Sjursen; Bjørn Ivar Haukanes; Eli Marie Grindedal; Harald Aarset; Astrid Stormorken; Lars F Engebretsen; Christoffer Jonsrud; Inga Bjørnevoll; Per Arne Andresen; Sarah Ariansen; Liss Anne S Lavik; Bodil Gilde; Inger Marie Bowitz-Lothe; Lovise Maehle; Pål Møller
Journal:  J Med Genet       Date:  2010-06-28       Impact factor: 6.318

Review 10.  Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Authors:  Henry T Lynch; Murray Joseph Casey; Carrie L Snyder; Chhanda Bewtra; Jane F Lynch; Matthew Butts; Andrew K Godwin
Journal:  Mol Oncol       Date:  2009-02-21       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.